The University of Chicago Header Logo

Connection

Mark Kozloff to Karnofsky Performance Status

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Karnofsky Performance Status.
Mark Kozloff
Connection Strength
0.033
Karnofsky Performance Status
  1. Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. J Clin Oncol. 2015 Dec 20; 33(36):4284-92.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.